Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
HeroMD (operated by Cured Med, LLC) is a men's health telehealth platform specializing in clinician-prescribed, compounded treatments for erectile dysfunction (ED). The company offers a frictionless, 100% online consultation process that connects patients with U.S.-licensed, board-certified physicians and LegitScript-certified compounding pharmacies. HeroMD's product portfolio features three distinct multi-compound formulations: 4-MAX (a sublingual liquid combining vardenafil, sildenafil, tadalafil, and apomorphine), Surge (an orally disintegrating tablet combining sildenafil and pycnogenol), and Prime (a daily chewing gum combining tadalafil, vardenafil, and vitamins D3 and K2). By utilizing sublingual, buccal, and orally disintegrating delivery formats, HeroMD aims to provide faster onset and spontaneous dosing options compared to traditional oral ED tablets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on HeroMD.